Abstract
Intranasal administration of acidic fibroblast growth factor suppressed the development of oligokinesia and muscular rigidity and elevated the content of dopamine and its metabolites (dihydroxyphenylacetic acid and homovanillic acid) in the striatum of 7-month-old mice with MPTP-induced Parkinsonian syndrome. In 14-month-old mice the antiparkinsonic effect of acidic fibroblast growth factor was weakened or absent. It is suggested that this factor is able to attenuate or postpone degeneration and death of nigral dopaminergic neurons.
Similar content being viewed by others
References
G. N. Kryzhanovskii, V. G. Kucheryanu, E. V. Nikushkin, and N. A. Krupina,Byull. Eksp. Biol. Med.,120, No. 9, 260–262 (1995).
A. Yu. Shemanov, I. I. Miroshnichenko, V. S. Kudrin, and K. S. Raevskii,Neurokhimiya,7, No. 3, 134–138 (1988).
A. J. Bean, R. Elde, Y. H. Cao, et al.,Proc. Natl. Acad. Sci. USA,88, 10237–10241 (1991).
G. Chadi, A. Moller, L. Rosen, et al.,Exp. Brain Res.,97, 145–158 (1993).
D. H. Damon, R. R. Lobb, P. A. D'Amore, and J. A. Wagner,J. Cell Physiol.,138, 221–226 (1989).
I. Date, M. Notter, S. Felten, and D. Felten,Brain Res.,526, 156–160 (1990).
B. K. Jin and L. D. Iacovitti,Neurobiol. Dis.,1, 1–12 (1995).
P. B. Kirschner, R. Henshaw, J. Weise, et al.,J. Cereb. Blood Flow Metab.,15, 619–623 (1995).
G. N. Kryzhanovsky, V. G. Kucheryanu, O. M. Pozdnyakov, et al.,Pathophysiology,4, 59–67 (1997).
A. Mitani, Y. Oomura, H. Yanase, and K. Kataoka,Neurochem. Int.,21, 337–341 (1992).
M. Radhakrishna and G. Almazan,Brain Res. Mol. Brain Res.,24, 118–128 (1994).
K. Sasaki, Y. Oomura, K. Suzuki, et al.,Neurochem. Int.,21, 397–402 (1992).
H. W. M. Steinbusch, R. J. Vermeulen, and J. A. D. M. Tonnaer,Prog. Brain Res.,82, 81–86 (1990).
N. Takei, H. Ogaki, and Y. Endo,Neurosci. Lett.,192, 124–126 (1995).
I. Tooyama, E. G. McGeer, T. Kawamata, et al.,Brain Res.,656, 165–168 (1994).
D. G. Walker, K. Terai, A. Matsuo, et al., —Ibid.,794, No. 2, 181–187 (1998).
Author information
Authors and Affiliations
Additional information
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 127, No. 5, pp. 502–505, May, 1999
Rights and permissions
About this article
Cite this article
Kucheryanu, V.G., Kryzhanovskii, G.N., Kudrin, V.S. et al. Effects of acidic fibroblast growth factor on the development of experimental parkinsonism and striatal level of dopamine and its metabolites in mice of different ages. Bull Exp Biol Med 127, 454–456 (1999). https://doi.org/10.1007/BF02434936
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02434936